Olcegepant is a potent calcitonin gene-related peptide (CGRP) receptor antagonist belonging to the gepant class of drugs, which is investigated for the acute treatment of migraine attacks by inhibiting… Read more
Olcegepant is a potent calcitonin gene-related peptide (CGRP) receptor antagonist belonging to the gepant class of drugs, which is investigated for the acute treatment of migraine attacks by inhibiting the signaling pathways responsible for pain transmission and vascular dilation. This category features high-quality reference standards of the Olcegepant active pharmaceutical ingredient, alongside its related impurities and metabolites. These compounds are essential for laboratories performing comprehensive impurity profiling, analytical method development, and rigorous quality control validation. Additionally, stable isotope labelled versions are available to serve as internal standards, facilitating accurate quantification in complex bioanalytical assays and pharmacokinetic studies. By providing these critical materials, the collection supports precise identification and verification of drug substances throughout the pharmaceutical development lifecycle, ensuring compliance with regulatory standards for safety and efficacy.